RBF Capital’s Usana Health Sciences USNA Stock Holding History

RBF Capital’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,000	Closed	-$224K	–	587
2022 Q3	$224K	Hold	4,000	–	–	0.02%	451
2022 Q2	$304K	Hold	4,000	–	–	0.02%	411
2022 Q1	$318K	Sell	4,000 -1,000	-20%	-$90.2K	0.02%	420
2021 Q4	$506K	Hold	5,000	–	–	0.03%	365
2021 Q3	$461K	Hold	5,000	–	–	0.03%	359
2021 Q2	$512K	Hold	5,000	–	–	0.03%	356
2021 Q1	$488K	Hold	5,000	–	–	0.03%	320
2020 Q4	$385K	Hold	5,000	–	–	0.03%	296
2020 Q3	$368K	Hold	5,000	–	–	0.04%	268
2020 Q2	$367K	Hold	5,000	–	–	0.04%	278
2020 Q1	$289K	Buy	+5,000	New	+$348K	0.04%	270
2019 Q1	–	Sell	-2,000	Closed	-$235K	–	421
2018 Q4	$235K	Hold	2,000	–	–	0.03%	306
2018 Q3	$241K	Hold	2,000	–	–	0.03%	325
2018 Q2	$231K	Buy	+2,000	New	+$219K	0.03%	325

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RBF Capital's USNA Position: Q4 2022 in Review

RBF Capital sold out of Usana Health Sciences (USNA) in Q4 2022, closing a stake of 4,000 shares — an estimated $224K sold.

RBF Capital first reported a position in USNA in Q2 2018 and held it in 14 quarters. The position peaked at $512K in Q2 2021. 167 funds tracked by Wall St. Rank hold USNA as of Q4 2022.

RBF Capital reported no remaining Usana Health Sciences position as of Q4 2022 after selling out during the quarter.
RBF Capital sold 4,000 Usana Health Sciences shares in Q4 2022, an estimated $224K.
RBF Capital first reported a position in Usana Health Sciences in Q2 2018 and held it in 14 quarters.
RBF Capital's Usana Health Sciences position peaked at $512K in Q2 2021.
167 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2022.

Based on RBF Capital's 13F filing for Q4 2022, filed 14 Feb 2023.